What is the therapeutic INR range for clients on anticoagulant therapy for DVT?

The therapeutic INR range for clients on anticoagulant therapy for deep vein thrombosis (DVT) is typically between 2.0 and 3.0. This range helps to ensure that the blood’s clotting ability is sufficiently inhibited to prevent further clot formation without increasing the risk of bleeding.

For patients being treated for DVT, an INR of 2.0 to 3.0 effectively balances the need for anticoagulation with the dangers posed by excessive bleeding, a common risk when INR levels are too high. Patients with an INR below 2.0 may not have adequate anticoagulation, which can increase the risk for thromboembolic events, while those with an INR higher than 3.0 are at an elevated risk for bleeding complications. Therefore, maintaining the INR within the 2.0 to 3.0 range is crucial for patients on anticoagulant therapy following DVT.